+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Gonadotropin-Releasing Hormone Modifies Action Potential Generation in Sheep Pars distalis Gonadotropes

      , ,


      S. Karger AG

      Gonadotropin-releasing hormone, Gonadotropes, Electrophysiology

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Cell-intact patch-clamp recording was used to determine the electrophysiological responses of sheep anterior pituitary gonadotropes to stimulation with gonadotropin-releasing hormone (GnRH). Cells were identified prior to recording by reverse haemolytic plaque assay (RHPA), or using morphological criteria in preparations enriched in gonadotropes by Percoll density gradient centrifugation. Most cells identified by RHPA did not generate action potentials, and responses to GnRH were inconsistent. The majority of gonadotropes in enriched preparations however spontaneously generated action potentials requiring the entry of both extracellular Na<sup>+</sup> and Ca<sup>2+</sup>, and involving tetra-ethylammonium-sensitive K<sup>+</sup> channels. Two-minute GnRH application (10<sup>–7</sup> M) evoked a characteristic sequence of changes in action potential generation. The immediate response was an inhibition of action potentials, followed by a recovery of these events, with a progressive decline in amplitude over about 10 min. The cells then remained quiescent for up to 1 h. The results indicate that GnRH may evoke an initial hyperpolarization involving Ca<sup>2+</sup>-dependent K<sup>+</sup> channels, followed by a sustained depolarizing response, with consequent inactivation of action potential generation.

          Related collections

          Author and article information

          S. Karger AG
          08 April 2008
          : 58
          : 6
          : 646-654
          Prince Henry’s Institute of Medical Research, Clayton, Australia
          126605 Neuroendocrinology 1993;58:646–654
          © 1993 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 9
          Regulation of Hypothalamic Neurons


          Comment on this article